A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Public ClinicalTrials.gov record NCT00196313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 13 weeks of treatment with the option to extend blinded therapy for an additional 13 weeks. The overall study duration will be 6-9 months. Patients will be required to record menstrual pain in a daily diary.
Study identification
- NCT ID
- NCT00196313
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 17 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2005
- Primary completion
- Sep 30, 2008
- Completion
- Sep 30, 2008
- Last update posted
- Sep 21, 2016
2005 – 2008
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duramed Investigational Site | Denver | Colorado | 80218-1088 | — |
| Duramed Investigational Site | Decatur | Georgia | 30034 | — |
| Duramed Investigational Site | Louisville | Kentucky | 40202 | — |
| Duramed Investigational Site | St Louis | Missouri | 63110 | — |
| Duramed Investigational Site | Cincinnati | Ohio | 45229 | — |
| Duramed Investigational Site | Cleveland | Ohio | 44109 | — |
| Duramed Investigational Site | Columbus | Ohio | 43205 | — |
| Duramed Investigational Site | Medford | Oregon | 97504 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Duramed Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Duramed Investigational Site | Willow Grove | Pennsylvania | 19090 | — |
| Duramed Investigational Site | Providence | Rhode Island | 02903 | — |
| Duramed Investigational Site | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00196313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00196313 live on ClinicalTrials.gov.